Rucaparib treatment could decrease KIAA1429 expression in both mRNA and protein levels, and suppress the proliferation of chronic myeloid leukemia cells. The gene discussed is VIRMA; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.